ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+1.27%(+0.011) Siku 1
13 Nov, 17:29:57 GMT +1 · SEK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ORX...
Fungua
SEKÂ 0.90
Juu
SEKÂ 0.90
Chini
SEKÂ 0.83
Mtaji wa soko
308.06M
Wastani wa kiasi cha mauzo
elfu 739.90
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 22.55
Chini kwa wiki 52
SEKÂ 0.80
EPS
SEKÂ 13.61
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Fungua
SEKÂ 0.90
Juu
SEKÂ 0.90
Chini
SEKÂ 0.83
Mtaji wa soko
308.06M
Wastani wa kiasi cha mauzo
elfu 739.90
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.06
Juu kwa wiki 52
SEKÂ 22.55
Chini kwa wiki 52
SEKÂ 0.80
EPS
SEKÂ 13.61
Hisa za wawekezaji
35.13M
Idadi ya wafanyakazi
55
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingKey
·
saa 1 iliyopita
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
saa 8 zilizopita
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
24/7 Wall St.
·
saa 4 zilizopita
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
saa 8 zilizopita
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Wasifu
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Kuhusu Orexo AB
Afisa Mkuu Mtendaji (CEO)Nikolaj Sørensen
Wafanyakazi55
Lilianzishwa1995
Makao makuu-
SektaHealth Care
Sekta-
Tovutiorexo.com